Cipta Sarana Medika Tbk. vs Gunung Raja Paksi Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Gunung Raja Paksi Tbk. trades at Rp296 (market cap 3.56T, 344.8K 24h volume). The key difference: Gunung Raja Paksi Tbk. is far larger — about 22.5× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 344.8K). Which is the better fit depends on your goals.
| DKHH | GGRP | |
|---|---|---|
Market Cap | 158.12B | 3.56T |
Volume | 8.21M | 344.8K |
Lot | 82.15K | 3.45K |
Turnover | 515.2M | 101.61M |
Average Price | 62.72 | 294.7 |
Value | 515.2M | 101.61M |
Indicative Equilibrium Price | 63 | 296 |
Indicative Equilibrium Volume | 1.33K | 15 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT. Gunung Raja Paksi Tbk (the Company) was established under the name of PT Gunung Naga Mas based on Notarial Deed No.229 of Chairani Bustami,S.H. dated August 20,1990 that was amended by Notarial Deed No.25 dated June 6,1991. The change from Foreign Capital Investment (“FCI”) to Domestic Capital Investment (“DCI”) has been approved by the Capital Investment Coordinating Board of the Republic of Indonesia in its Letter No.346/1/IP/PMDN/2016 dated December 15, 2016.
Read more on GGRP →